Initiator Pharma  logo — Empowering Lives Through Meaningful Therapies

Initiator Pharma

Empowering Lives Through Meaningful Therapies

Founded 2016 Denmark Denmark 9 employees Secondary Market Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name Initiator Pharma
Founded Year 2016
Location Denmark Denmark +1
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Secondary Market
Social

Get notified when Initiator Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Initiator Pharma

Initiator Pharma is a Denmark-based biotechnology startup focusing on developing cutting-edge drugs to address unmet medical needs within the central and peripheral nervous system. The company's clinical-stage pipeline includes three programs, with a focus on addressing erectile dysfunction of psychogenic and organic origin and a neuropathic pain program. Notably, their recent advancement in drug development has shown significant efficacy in preclinical models for Female Sexual Dysfunction (FSD). Since its founding in 2016, Initiator Pharma continues to make strides in developing innovative therapies. In April 2022, the company secured a kr20.00MSecondary Market investment with the participation of Adrigo Asset Management and Linc AB. Initiator Pharma's dedication to addressing significant medical challenges and their success in securing investment reflects the potential for meaningful impact and growth in the pharmaceutical industry. With a compelling slogan of "Empowering Lives Through Meaningful Therapies", Initiator Pharma is positioned as a promising player in the healthcare and pharmaceutical sectors.

Taxonomy: pharmaceuticals, clinical-stage, biotech, drug development, neuroscience, erectile dysfunction, neuropathic pain, FSD, clinical trials, innovation, Denmark, stock exchange, quality of life, patient-centered

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Secondary Market •••••• 2
Investor Investor
13 Apr 2022

Initiator Pharma Alternatives & Competitors

Initiator Pharma vs

Pioneering advanced immunotherapies to amplify cancer treatment options and improve patient outcomes...

Series C
11-50 employees
Biotechnology, Health and Wellness
Initiator Pharma vs

Committed to Innovation in Mitochondrial Therapies

Post Ipo Equity
72 employees
Biopharma, Biotechnology
Initiator Pharma vs
Allyx Therapeutics
Allyx Therapeutics United States

Protecting Synapses and Reversing Neurodegeneration

Series Unknown
5 employees
Biotechnology, Health Care

FAQ About Initiator Pharma

Empowering Lives Through Meaningful Therapies
Initiator Pharma was founded in 2016.
Initiator Pharma is headquartered in Denmark.
Initiator Pharma operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Initiator Pharma has approximately 9 employees.
Initiator Pharma has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Secondary Market.
Top alternatives and competitors to Initiator Pharma include Checkmate Pharmaceuticals, Stealth BioTherapeutics, Allyx Therapeutics, Minovia Therapeutics , AIBODY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Initiator Pharma and Checkmate Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Initiator Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy